Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 3:52 pm Sale | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 3,526,304 8.56% | -1,087,028![]() (-23.56%) | View |
2021-06-01 2:00 pm Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 4,613,332 11.18% | 2,404,548![]() (+108.86%) | View |
2021-05-11 1:13 pm Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,208,784 5.35% | 298,590![]() (+15.63%) | View |
2021-03-11 11:12 am Sale | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,910,194 4.63% | -90,394![]() (-4.52%) | View |
2021-02-10 12:04 pm Sale | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | VANGUARD GROUP INC | 1,035,402 3.52% | -638,560![]() (-38.15%) | View |
2021-02-05 8:34 pm Sale | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | RAPP MICHAEL | 0 0% | -1,490,000![]() (Position Closed) | View |
2021-01-08 1:04 pm Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,000,588 6.8% | 421,427![]() (+26.69%) | View |
2020-11-16 12:05 pm Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,579,161 5.36% | 371,035![]() (+30.71%) | View |
2020-07-10 10:39 am Sale | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | BlackRock Inc. BLK | 438,643 1.8% | -1,074,962![]() (-71.02%) | View |
2020-05-11 2:43 pm Sale | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,208,126 4.84% | -1,475,277![]() (-54.98%) | View |
2020-02-11 4:39 pm Sale | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | VANGUARD GROUP INC | 1,673,962 7.21% | -1,036,733![]() (-38.25%) | View |
2020-02-07 08:45 am Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | BlackRock Inc. BLK | 1,513,605 6.5% | 841,289![]() (+125.13%) | View |
2019-12-02 1:37 pm Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,683,403 8.3% | 459,630![]() (+20.67%) | View |
2019-06-04 09:41 am Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,223,773 10.55% | 2,223,773![]() (New Position) | View |
2019-01-29 12:41 pm Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | GENESIS CAPITAL ADVISORS LLC | 797,477 4.52% | 47,513![]() (+6.34%) | View |
2019-01-15 4:43 pm Purchase | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | RAPP MICHAEL | 1,490,000 8.45% | 20,885![]() (+1.42%) | View |